ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marcio Scorsin
Philippe Menasché
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pouzet, B.
Right arrow Articles by Menasché, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pouzet, B.
Right arrow Articles by Menasché, P.
Related Collections
Right arrow Molecular biology

Ann Thorac Surg 2001;71:844-851
© 2001 The Society of Thoracic Surgeons


Original article: cardiovascular

Factors affecting functional outcome after autologous skeletal myoblast transplantation

Bruno Pouzet, MDa, Jean-Thomas Vilquin, PhDb, Albert A. Hagège, MD, PhDc, Marcio Scorsin, MD, PhDa, Emmanuel Messas, MDc, Marc Fiszman, PhDb, Ketty Schwartz, PhDb, Philippe Menasché, MD, PhDa

a Department of Cardiovascular Surgery, Hôpital Bichat, Paris, France
b INSERM U523, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtriére, Paris, France
c Department of Cardiology, Hôpital Boucicaut, Paris, France

Address reprint requests to Dr Menasché, Service de Chirurgie Cardiovasculaire B, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri Huchard, 75877 Paris Cedex 18, France
e-mail: ccv-bloc.sec3{at}bch.ap-hop-paris.fr

Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.

Background. This study assessed the extent to which the initial degree of functional impairment and the number of injected cells may influence the functional improvement provided by autologous skeletal myoblast transplantation into infarcted myocardium.

Methods. One week after left coronary artery ligation, 44 rats received into the infarcted scar, autologous skeletal myoblasts expanded in vitro for 7 days (mean, 3.5 x 106, n = 21), or culture medium alone (controls, n = 23). Left ventricular function was assessed by two-dimensional echocardiography.

Results. When transplanted hearts were stratified according to their baseline ejection fraction, a significant improvement occurred at 2 months in the less than 25% (from 21.4% to 37%), 25% to 35% (from 29% to 43.8%), and in the 35% to 40% (from 37.2% to 41.7%) groups, compared to controls (p = 0.048, 0.0057, and 0.034, respectively), but not in the more than 40% stratum. A significant linear relationship was found between the improvement in ejection fraction and the number of injected myoblasts, both at 1 and 2 months after transplantation (p < 0.0001).

Conclusions. Autologous myoblast transplantation is functionally effective over a wide range of postinfarct ejection fractions, including in the sickest hearts provided that they are injected with a sufficiently high number of cells.




This article has been cited by other articles:


Home page
Eur Heart JHome page
J. J. Gavira, E. Nasarre, G. Abizanda, M. Perez-Ilzarbe, A. de Martino-Rodriguez, J. A. Garcia de Jalon, M. Mazo, A. Macias, I. Garcia-Bolao, B. Pelacho, et al.
Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction
Eur. Heart J., August 22, 2009; (2009) ehp342v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Lu, H. K. Haider, S. Jiang, and M. Ashraf
Sca-1+ Stem Cell Survival and Engraftment in the Infarcted Heart: Dual Role for Preconditioning-Induced Connexin-43
Circulation, May 19, 2009; 119(19): 2587 - 2596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Lee, M. A. Stagg, S. Fukushima, G. K. R. Soppa, U. Siedlecka, S. J. Youssef, K. Suzuki, M. H. Yacoub, and C. M. N. Terracciano
Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H927 - H936.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Hamamoto, J. H. Gorman III, L. P. Ryan, R. Hinmon, T. P. Martens, M. D. Schuster, T. Plappert, M. Kiupel, M. G. St. John-Sutton, S. Itescu, et al.
Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.
Ann. Thorac. Surg., March 1, 2009; 87(3): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
N. Dib, J. Dinsmore, Z. Lababidi, B. White, S. Moravec, A. Campbell, A. Rosenbaum, K. Seyedmadani, W. A. Jaber, C. S. Rizenhour, et al.
One-Year Follow-Up of Feasibility and Safety of the First U.S., Randomized, Controlled Study Using 3-Dimensional Guided Catheter-Based Delivery of Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy (CAuSMIC Study)
J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 9 - 16.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Okada, T. R. Payne, B. Zheng, H. Oshima, N. Momoi, K. Tobita, B. B. Keller, J. A. Phillippi, B. Peault, and J. Huard
Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium
J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1869 - 1880.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Guo, H. Kh. Haider, C. Wang, R.-S. Tan, W. S.N. Shim, P. Wong, and E. K.W. Sim
Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation
Ann. Thorac. Surg., December 1, 2008; 86(6): 1841 - 1848.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
N. Bonaros, R. Rauf, E. Werner, B. Schlechta, E. Rohde, A. Kocher, J. Bonatti, and G. Laufer
Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure
Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 249 - 255.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
B.-O. Kim, S. Verma, R. D. Weisel, S. Fazel, Z.-Q. Jia, T. Mizuno, and R.-K. Li
Preservation of heart function in diabetic rats by the combined effects of muscle cell implantation and insulin therapy
Eur J Heart Fail, January 1, 2008; 10(1): 14 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Guo, H. Kh. Haider, W. S.N. Shim, R.-S. Tan, L. Ye, S. Jiang, P. K. Law, P. Wong, and E. K.W. Sim
Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation.
J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1332 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. I. Niagara, H. Kh. Haider, S. Jiang, and M. Ashraf
Pharmacologically Preconditioned Skeletal Myoblasts Are Resistant to Oxidative Stress and Promote Angiomyogenesis via Release of Paracrine Factors in the Infarcted Heart
Circ. Res., March 2, 2007; 100(4): 545 - 555.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. J. Gavira, M. Perez-Ilzarbe, G. Abizanda, A. Garcia-Rodriguez, J. Orbe, J. A. Paramo, M. Belzunce, G. Rabago, J. Barba, J. Herreros, et al.
A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction
Cardiovasc Res, September 1, 2006; 71(4): 744 - 753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Nakamura, T. Yasuda, R. D. Weisel, and R.-K. Li
Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H939 - H947.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Siepe, M.-N. Giraud, M. Pavlovic, C. Receputo, F. Beyersdorf, P. Menasche, T. Carrel, and H. T. Tevaearai
Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure
J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 124 - 131.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. E. Murry, H. Reinecke, and L. M. Pabon
Regeneration Gaps: Observations on Stem Cells and Cardiac Repair
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. J. Gavira, J. Herreros, A. Perez, M. J. Garcia-Velloso, J. Barba, F. Martin-Herrero, C. Canizo, A. Martin-Arnau, J. M. Marti-Climent, M. Hernandez, et al.
Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up
J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 799 - 804.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. E. Murry, L. J. Field, and P. Menasche
Cell-Based Cardiac Repair: Reflections at the 10-Year Point
Circulation, November 15, 2005; 112(20): 3174 - 3183.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. M. Yau, C. Kim, D. Ng, G. Li, Y. Zhang, R. D. Weisel, and R.-K. Li
Increasing Transplanted Cell Survival With Cell-Based Angiogenic Gene Therapy
Ann. Thorac. Surg., November 1, 2005; 80(5): 1779 - 1786.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. H.L. Tang, S. Fazel, R. D. Weisel, S. Verma, and R.-K. Li
Optimizing cardiac cell therapy: From processing to delivery
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 966 - 968.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. I. McConnell, C. L. del Rio, D. B. Jacoby, M. Pavlicova, P. Kwiatkowski, A. Zawadzka, J. H. Dinsmore, L. Astra, S. Wisel, and R. E. Michler
Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1001 - 1001.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Tambara, G. U. Premaratne, G. Sakaguchi, N. Kanemitsu, X. Lin, H. Nakajima, Y. Sakakibara, Y. Kimura, M. Yamamoto, Y. Tabata, et al.
Administration of Control-Released Hepatocyte Growth Factor Enhances the Efficacy of Skeletal Myoblast Transplantation in Rat Infarcted Hearts by Greatly Increasing Both Quantity and Quality of the Graft
Circulation, August 30, 2005; 112(9_suppl): I-129 - I-134.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Azarnoush, A. Maurel, L. Sebbah, C. Carrion, A. Bissery, C. Mandet, J. Pouly, P. Bruneval, A. A. Hagege, and P. Menasche
Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1{alpha}
J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Yasuda, R. D. Weisel, C. Kiani, D. A.G. Mickle, M. Maganti, and R.-K. Li
Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 904 - 911.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Davani, F. Deschaseaux, D. Chalmers, P. Tiberghien, and J.-P. Kantelip
Can stem cells mend a broken heart?
Cardiovasc Res, February 1, 2005; 65(2): 305 - 316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-B. Liu, P. W. M. Fedak, R. D. Weisel, T. Yasuda, G. Kiani, D. A. G. Mickle, Z.-Q. Jia, and R.-K. Li
Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2840 - H2849.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. C. Smits, R.-J. M. van Geuns, D. Poldermans, M. Bountioukos, E. E. M. Onderwater, C. H. Lee, A. P. W. M. Maat, and P. W. Serruys
Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with Six-Month Follow-Up
J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2063 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Fujii, T. M. Yau, R. D. Weisel, N. Ohno, D. A. G. Mickle, N. Shiono, T. Ozawa, K. Matsubayashi, and R.-K. Li
Cell transplantation to prevent heart failure: a comparison of cell types
Ann. Thorac. Surg., December 1, 2003; 76(6): 2062 - 2070.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Herreros, F. Prosper, A. Perez, J. J Gavira, M. J. Garcia-Velloso, J. Barba, P. L Sanchez, C. Canizo, G. Rabago, J. M Marti-Climent, et al.
Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction
Eur. Heart J., November 2, 2003; 24(22): 2012 - 2020.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Tambara, Y. Sakakibara, G. Sakaguchi, F. Lu, G. U. Premaratne, X. Lin, K. Nishimura, and M. Komeda
Transplanted Skeletal Myoblasts Can Fully Replace the Infarcted Myocardium When They Survive in the Host in Large Numbers
Circulation, September 9, 2003; 108(90101): II-259 - 263.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. B. Thompson, S. M. Emani, B. H. Davis, E. J. van den Bos, Y. Morimoto, D. Craig, D. Glower, and D. A. Taylor
Comparison of Intracardiac Cell Transplantation: Autologous Skeletal Myoblasts Versus Bone Marrow Cells
Circulation, September 9, 2003; 108(90101): II-264 - 271.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. H.L. Tang, P. W.M. Fedak, T. M. Yau, R. D. Weisel, A. Kulik, D. A.G. Mickle, and R.-K. Li
Cell transplantation to improve ventricular function in the failing heart
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 907 - 916.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Menasche
Cell transplantation in myocardium
Ann. Thorac. Surg., June 1, 2003; 75(90060): S20 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. K. W, H. K. Haider, and P. K. Law
Single fiber skeletal muscle transplantation or purified myoblast engraftment?
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1181 - 1182.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. D. Dowell, M. Rubart, K. B.S. Pasumarthi, M. H. Soonpaa, and L. J. Field
Myocyte and myogenic stem cell transplantation in the heart
Cardiovasc Res, May 1, 2003; 58(2): 336 - 350.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Menasche
Skeletal muscle satellite cell transplantation
Cardiovasc Res, May 1, 2003; 58(2): 351 - 357.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Reffelmann and R. A. Kloner
Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure?
Cardiovasc Res, May 1, 2003; 58(2): 358 - 368.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Agbulut, M.-L. Menot, Z. Li, F. Marotte, D. Paulin, A. A. Hagege, C. Chomienne, J.-L. Samuel, and P. Menasche
Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy
Cardiovasc Res, May 1, 2003; 58(2): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Menasche, A. A. Hagege, J.-T. Vilquin, M. Desnos, E. Abergel, B. Pouzet, A. Bel, S. Sarateanu, M. Scorsin, K. Schwartz, et al.
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction
J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1078 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Minami, H. Reinecke, and C. E. Murry
Skeletal muscle meets cardiac muscle: Friends or foes?
J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1084 - 1086.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Al Attar, C. Carrion, S. Ghostine, I. Garcin, J.-T. Vilquin, A. A. Hagege, and P. Menasche
Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat
Cardiovasc Res, April 1, 2003; 58(1): 142 - 148.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. D. Pagani, H. DerSimonian, A. Zawadzka, K. Wetzel, A. S. B. Edge, D. B. Jacoby, J. H. Dinsmore, S. Wright, T. H. Aretz, H. J. Eisen, et al.
Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: Histological analysis of cell survival and differentiation
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 879 - 888.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750.
[Full Text]


Home page
Eur Heart J SupplHome page
P Menasche and M Desnos
Cardiac reparation: fixing the heart with cells, new vessels and genes
Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D73 - D81.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
C.E. MURRY, M.L. WHITNEY, M.A. LAFLAMME, H. REINECKE, and L.J. FIELD
Cellular Therapies for Myocardial Infarct Repair
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 519 - 526.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. C. Gorman and J. H. Gorman III
Cellular myoplasty: what are we really trying to achieve?
Ann. Thorac. Surg., January 1, 2002; 73(1): 342 - 343.
[Full Text] [PDF]


Home page
CirculationHome page
B. Pouzet, S. Ghostine, J.-T. Vilquin, I. Garcin, M. Scorsin, A. A. Hagege, D. Duboc, K. Schwartz, and P. Menasche
Is Skeletal Myoblast Transplantation Clinically Relevant in the Era of Angiotensin-Converting Enzyme Inhibitors?
Circulation, September 18, 2001; 104 (2009): I-223 - I-228.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.